Concepedia

Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors

Mohamed Elagawany, Mohamed A. Ibrahim, Hany E. A. Ahmed, Abd-Allah S. El-Etrawy, Adel Ghiaty, Zakaria K. Abdel‐Samii, Said El‐Feky, Jürgen Bajorath

Bioorganic & Medicinal Chemistry Letters · 2013 · 33 citations · 14 references

DOIFull text

Open access

Concepts

References

14

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

Tianbo Liu, Yu‐Ting Lin, X. Wen et al. · Nucleic Acids Research · 2006 · 2.1K citations · Full text

, , +17

Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine spongeconstituent

Laurent Meijer, AW White, Matthieu Garnier et al. · Chemistry & Biology · 2000 · 448 citations · Full text

, , +10

First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors:  Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2002 · 447 citations · Full text

, , +13

Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases

Panagiotis Polychronopoulos, Prokopios Magiatis, Alexios‐Léandros Skaltsounis et al. · Journal of Medicinal Chemistry · 2004 · 376 citations · Full text

, , +10

Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure–Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s Disease

Mark T. Hamann, D. A. Alonso, Ester Martı́n-Aparicio et al. · Journal of Natural Products · 2007 · 145 citations · Full text

, , +16